MLICM
AMRI

Metropolitan Life Insurance Company (MetLife)’s Albany Molecular Research Inc AMRI Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-18,917
Closed -$410K – 2588
2017
Q2 		$410K Hold
18,917
– – ﹤0.01% 1849
2017
Q1 		$265K Hold
18,917
– – ﹤0.01% 2083
2016
Q4 		$355K Hold
18,917
– – ﹤0.01% 1970
2016
Q3 		$312K Hold
18,917
– – ﹤0.01% 2040
2016
Q2 		$254K Hold
18,917
– – ﹤0.01% 2165
2016
Q1 		$289K Hold
18,917
– – ﹤0.01% 1928
2015
Q4 		$376K Hold
18,917
– – ﹤0.01% 1823
2015
Q3 		$330K Sell
18,917
-29
-0.2% -$590 ﹤0.01% 1918
2015
Q2 		$383K Sell
18,946
-799
-4% -$15.4K ﹤0.01% 1935
2015
Q1 		$348K Hold
19,745
– – ﹤0.01% 1759
2014
Q4 		$321K Hold
19,745
– – ﹤0.01% 2083
2014
Q3 		$436K Hold
19,745
– – ﹤0.01% 1801
2014
Q2 		$397K Hold
19,745
– – ﹤0.01% 2007
2014
Q1 		$367K Hold
19,745
– – ﹤0.01% 2018
2013
Q4 		$199K Hold
19,745
– – ﹤0.01% 2478
2013
Q3 		$255K Hold
19,745
– – ﹤0.01% 2236
2013
Q2 		$234K Buy
+19,745
New +$214K ﹤0.01% 2240

Other funds holding AMRI

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s AMRI Position: Q3 2017 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 18,917 shares — an estimated $410K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in AMRI in Q2 2013 and held it in 17 quarters. The position peaked at $436K in Q3 2014. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 18,917 Albany Molecular Research Inc shares in Q3 2017, an estimated $410K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Albany Molecular Research Inc in Q2 2013 and held it in 17 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Albany Molecular Research Inc position peaked at $436K in Q3 2014.
  • 2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q3 2017, filed 14 Nov 2017.